Eagle Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $37.1M | Sell |
575,604
-844,579
| -59% | -$54.5M | 0.19% | 133 |
|
|
2024
Q2 | $111M | Sell |
1,420,183
-10,693
| -0.7% | -$833K | 0.59% | 57 |
|
|
2024
Q1 | $96.2M | Buy |
1,430,876
+82,911
| +6% | +$5.58M | 0.49% | 77 |
|
|
2023
Q4 | $90.8M | Sell |
1,347,965
-597,005
| -31% | -$40.2M | 0.49% | 85 |
|
|
2023
Q3 | $132M | Buy |
1,944,970
+351,479
| +22% | +$23.8M | 0.78% | 33 |
|
|
2023
Q2 | $114M | Sell |
1,593,491
-59,587
| -4% | -$4.26M | 0.64% | 52 |
|
|
2023
Q1 | $115M | Sell |
1,653,078
-12,833
| -0.8% | -$891K | 0.67% | 54 |
|
|
2022
Q4 | $115M | Sell |
1,665,911
-139,958
| -8% | -$9.7M | 0.71% | 41 |
|
|
2022
Q3 | $99M | Buy |
1,805,869
+159,869
| +10% | +$8.77M | 0.65% | 47 |
|
|
2022
Q2 | $109M | Buy |
1,646,000
+2,465
| +0.1% | +$163K | 0.68% | 38 |
|
|
2022
Q1 | $109M | Buy |
1,643,535
+169,898
| +12% | +$11.3M | 0.56% | 62 |
|
|
2021
Q4 | $86.2M | Sell |
1,473,637
-12,989
| -0.9% | -$759K | 0.38% | 99 |
|
|
2021
Q3 | $89.3M | Buy |
1,486,626
+1,471,500
| +9,728% | +$88.4M | 0.4% | 93 |
|
|
2021
Q2 | $906K | Buy |
15,126
+1,143
| +8% | +$68.5K | ﹤0.01% | 516 |
|
|
2021
Q1 | $692K | Buy |
13,983
+9,193
| +192% | +$455K | ﹤0.01% | 524 |
|
|
2020
Q4 | $239K | Sell |
4,790
-8,597
| -64% | -$429K | ﹤0.01% | 498 |
|
|
2020
Q3 | $737K | Sell |
13,387
-579
| -4% | -$31.9K | ﹤0.01% | 493 |
|
|
2020
Q2 | $738K | Buy |
+13,966
| New | +$738K | ﹤0.01% | 501 |
|